Newman Dignan & Sheerar, Inc.
Source: SEC Form 13F · as of Mar 2026Newman Dignan & Sheerar, Inc. holds 12 biotech & pharma companies tracked by BioSniper, totaling $17.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$17.0M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 21,364 | $5.2M |
| MRKMerck & Co., Inc. | 28,802 | $3.5M |
| AMGNAMGEN INC | 7,625 | $2.7M |
| BMYBRISTOL MYERS SQUIBB CO | 17,477 | $1.1M |
| LLYELI LILLY & Co | 1,035 | $952K |
| ABBVAbbVie Inc. | 4,257 | $926K |
| NVSNovartis AG | 3,499 | $534K |
| ABTABBOTT LABORATORIES | 4,969 | $510K |
| PFEPFIZER INC | 16,929 | $475K |
| INCYIncyte Corp. | 4,401 | $414K |
| PMPhilip Morris International Inc | 2,174 | $359K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 792 | $354K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.